Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ... Gastroenterology 141 (1), 338-347, 2011 | 497 | 2011 |
Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study P Nicoletti, GP Aithal, ES Bjornsson, RJ Andrade, A Sawle, M Arrese, ... Gastroenterology 152 (5), 1078-1089, 2017 | 215 | 2017 |
Drug‐induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France E Bondon‐Guitton, S Perez‐Lloret, H Bagheri, C Brefel, O Rascol, ... Movement disorders 26 (12), 2226-2231, 2011 | 184 | 2011 |
Pharmacovigilance, risks and adverse effects of self-medication JL Montastruc, E Bondon-Guitton, D Abadie, I Lacroix, A Berreni, ... Therapies 71 (2), 257-262, 2016 | 141 | 2016 |
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. HF Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, ... Fundamental Clin Pharmacol 29 (1), 106-11, 2015 | 115 | 2015 |
Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population P Hallberg, N Eriksson, L Ibañez, E Bondon-Guitton, R Kreutz, A Carvajal, ... The Lancet Diabetes & Endocrinology 4 (6), 507-516, 2016 | 91 | 2016 |
Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants O Laccourreye, A Werner, JP Giroud, V Couloigner, P Bonfils, ... European annals of otorhinolaryngology, head and neck diseases 132 (1), 31-34, 2015 | 91 | 2015 |
Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database MJL Fuzier R1, Serres I, Guitton E, Lapeyre-Mestre M, FNP Centres. Drug Saf 36 (1), 55-62, 2013 | 71 | 2013 |
Adverse drug reactions to self‐medication: a study in a pharmacovigilance database A Berreni, F Montastruc, E Bondon‐Guitton, V Rousseau, D Abadie, ... Fundamental & clinical pharmacology 29 (5), 517-520, 2015 | 69 | 2015 |
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France F Montastruc, A Sommet, E Bondon-Guitton, G Durrieu, E Bui, H Bagheri, ... European journal of clinical pharmacology 68, 767-775, 2012 | 56 | 2012 |
A comparative study of QT prolongation with serotonin reuptake inhibitors A Ojero-Senard, J Benevent, E Bondon-Guitton, G Durrieu, L Chebane, ... Psychopharmacology 234, 3075-3081, 2017 | 51 | 2017 |
Drug‐induced gingival overgrowth: a study in the F rench P harmacovigilance D atabase E Bondon‐Guitton, H Bagheri, JL Montastruc, ... Journal of clinical periodontology 39 (6), 513-518, 2012 | 48 | 2012 |
Completeness of spontaneous adverse drug reaction reports sent by general practitioners to a regional pharmacovigilance centre: a descriptive study G Durrieu, J Jacquot, M Mège, E Bondon-Guitton, V Rousseau, ... Drug safety 39, 1189-1195, 2016 | 45 | 2016 |
Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and … MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ... Gastroenterology 141 (1), 338-347, 2011 | 38 | 2011 |
Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors E Faye, E Bondon-Guitton, P Olivier-Abbal, JL Montastruc, ... European journal of clinical pharmacology 69, 1819-1826, 2013 | 35 | 2013 |
Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics E Patras de Campaigno, E Bondon‐Guitton, G Laurent, F Montastruc, ... British Journal of Clinical Pharmacology 83 (7), 1544-1555, 2017 | 32 | 2017 |
Can drugs induce or aggravate sleep apneas? A case–noncase study in VigiBase®, the WHO pharmacovigilance database M Linselle, A Sommet, E Bondon‐Guitton, F Moulis, G Durrieu, ... Fundamental & clinical pharmacology 31 (3), 359-366, 2017 | 32 | 2017 |
Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: A PharmacoVigilance study in France AC Danton, F Montastruc, A Sommet, G Durrieu, H Bagheri, ... European journal of clinical pharmacology 69, 885-888, 2013 | 32 | 2013 |
Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients LMM Guitton E1, Montastruc JL, FNP Centres. Eur J Clin Pharmacol 62 (3), 243-9, 2006 | 32 | 2006 |
Undesirable effects related to oral antineoplastic drugs: comparison between patients’ internet narratives and a national pharmacovigilance database A Pages, E Bondon-Guitton, JL Montastruc, H Bagheri Drug safety 37, 629-637, 2014 | 29 | 2014 |